Citation 101304

TANAKA,H: MATSUZAKI,K: NAKASHIMA,H: OGINO,T: MATSUMOTO,A: IKEDA,H: WOODRUFF,HB: OMURA,S:. (1997). CHLOROPEPTINS, NEW ANTI-HIV ANTIBIOTICS INHIBITING GP120-CD4 BINDING FROM STREPTOMYCES SP. I. TAXONOMY, FERMENTATION, ISOLATION AND PHYSICO-CHEMICAL PROPERTIES AND BIOLOGICAL ACTIVITIES.. 50(1)

Citation Details

TitleCHLOROPEPTINS, NEW ANTI-HIV ANTIBIOTICS INHIBITING GP120-CD4 BINDING FROM STREPTOMYCES SP. I. TAXONOMY, FERMENTATION, ISOLATION AND PHYSICO-CHEMICAL PROPERTIES AND BIOLOGICAL ACTIVITIES.
AuthorsTANAKA,H: MATSUZAKI,K: NAKASHIMA,H: OGINO,T: MATSUMOTO,A: IKEDA,H: WOODRUFF,HB: OMURA,S:
Year1997
Volume50
Issue1

Summary

Year: 1997

Journal: Unknown

Organisms and Their Experiments (1)

Streptomyces species (STREPTOMYCETACEAE)

Experiment #Pharmacology TypeWorktypesCompoundResults
1Not specified
UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA
CHLOROPEPTIN I
None
2
GP120 BINDING TO CD4+ CELLS INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
CHLOROPEPTIN I
ACTIVE
3
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
CHLOROPEPTIN I
ACTIVE
4
VIRUS FOCUS FORMATION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
CHLOROPEPTIN I
ACTIVE
5
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CHLOROPEPTIN I
INACTIVE
6
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
CHLOROPEPTIN I
WEAK ACTIVITY
7
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
CHLOROPEPTIN I
WEAK ACTIVITY
8
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
CHLOROPEPTIN I
WEAK ACTIVITY
9
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CHLOROPEPTIN I
WEAK ACTIVITY
10
ANTIMYCOPLASMAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
CHLOROPEPTIN I
WEAK ACTIVITY
11
ANTIMYCOPLASMAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
CHLOROPEPTIN I
WEAK ACTIVITY
12Not specified
UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATA
COMPLESTATIN
None
13
GP120 BINDING TO CD4+ CELLS INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
COMPLESTATIN
ACTIVE
14
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
COMPLESTATIN
ACTIVE
15
VIRUS FOCUS FORMATION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
COMPLESTATIN
ACTIVE
16
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
COMPLESTATIN
EQUIVOCAL
17
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
COMPLESTATIN
WEAK ACTIVITY
18
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
COMPLESTATIN
WEAK ACTIVITY
19
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
COMPLESTATIN
NOT POSSIBLE TO INTERPRET RESULTS
20
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
COMPLESTATIN
WEAK ACTIVITY
21
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
COMPLESTATIN
WEAK ACTIVITY
22
ANTIMYCOPLASMAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
COMPLESTATIN
WEAK ACTIVITY
Show SPARQL Queries (1)